secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2026-06-16T20:12:10+00:00
Accession:  0001649094-26-000021
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte shareholders re-elect all three Class III directors, ratify Deloitte, approve say-on-pay
--------------------------------------------------------------------------------

- Three Class III directors re-elected: Brandicourt (116.4M for), Gilbert (114.7M for), Pickering (132.1M for); 4.4M broker non-votes.
- Ratification of Deloitte as auditor for FY2026 passed with 137.2M for, 137,589 against, 862 abstain.
- Non-binding advisory vote on named executive officer compensation approved with 130.0M for, 2.8M against, 247,195 abstain, 4.4M broker non-votes.
- All proposals passed as recommended by the board; no material strategic or financial changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000164909426000021/0001649094-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000164909426000021/pcvx-20260615.htm
  HTML page:      https://secwatch.observer/filing/0001649094-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer